Abstract
Radioimmunoscintigraphy is the administration of radio-labeled monoclonal antibodies (MAbs) and imaging with an external gamma camera. In this study, the ability of a new bifunctional N2S2 ligand, (succinimidyl 3,6-diaza-5-oxo-3-[2-((triphenylmethyl)thio)ethyl]-8-[(triphenylmethyl)thio]octanoate) (SOCTA), was evaluated for labeling of trastuzumab (a humanized anti-HER2/neu MAb) with 99mTc. Trastuzumab was labeled with 99mTc using SOCTA. The radiochemical purity, stability, immunoreactivity, biodistribution and imaging study was performed in the mice bearing breast tumor. The good results showed that SOCTA has the good potentials as a chelator for radiolabeling of antibody with 99mTc that needs more investigation in the future.
Similar content being viewed by others
References
James FR, Wootton S, Jackson A, Wiseman M, Copson ER, Cutress RI (2015) Obesity in breast cancer—what is the risk factor? Eur J Cancer. doi:10.1016/j.ejca.2015-01-057
Wiele C, Revets H, Mertens N (2004) Radioimmunoimaging: advances and prospects. Q J Nucl Med Mol Imaging 48:317–325
Lee SY, Hong YD, Kim HS, Choi SJ (2013) Synthesis and application of a novel cysteine-based DTPA-NCS for targeted radioimmunotherapy. Nucl Med Biol 40:424–429
Yousefnia H, Radfar E, Jalilian AR, Bahrami-Samani A, Shirvani-Arani S, Arbabi A, Ghannadi-Maragheh M (2011) Development of 177Lu-DOTA-anti-CD20 for radioimmunotherapy. J Radioanal Nucl Chem 287:199–209
Garcia MF, Calzada V, Camacho X, Goicochea E, Gambini JP, Quinn TP, Porcal W, Cabral P (2014) Microwave-assisted synthesis of HYNIC protected analogue for 99mTc labeled antibody. Curr Radiopharm 7:84–90
Liu L, Zhong G, Wei Y, Zhang M, Wang X (2011) Synthesis and biological evaluation of a novel 99mTc complex of HYNIC-conjugated aminomethylenediphosphonate as a potential bone imaging agent. J Radioanal Nucl Chem 288:467–473
Liu L, Zhang M, Zhong G, Wang X (2011) Synthesis and biodistribution of a novel 99mTc complex of HYNIC-conjugated metronidazole as a potential tumor hypoxia imaging agent. J Radioanal Nucl Chem 287:847–852
Liu L, Zhao M, Wang Z, Qin Y, Wang X (2014) Synthesis and biological evaluation of novel technetium-99m-labeled HYNIC–d-glucose as a potential tumor imaging agent. J Radioanal Nucl Chem 301:731–737
Luo TY, Tang IC, Wu YL, Hsu KL, Liu SW, Kung HC, Lai PS, Lin WJ (2009) Evaluating the potential of 188Re-SOCTA–trastuzumab as a new radioimmunoagent for breast cancer treatment. Nucl Med Biol 36:81–88
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Abrams MJ, Juweid M, Tenkate CI (1990) Technetium-99m human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med 31:2022–2028
Baidoo KE, Scheffel U, Lever SZ (1990) 99mTc labeling of proteins: initial evaluation of a novel diaminedithiol bifunctional chelating agent. Cancer Res 50:799–803
Hnatowich DJ, Mardirossian G, Rusckowski M, Fogarasi M, Virzi F, Winnard P (1993) Directly and indirectly technetium-99m-labeled antibodies—a comparison of in vitro and animal in vivo properties. J Nucl Med 34:109–111
Rajabifar S, Akhlaghi M, Jalilian AR, Bolourinovin F, Maashkar B, Talebimehrdar M, Ghafouri M (2009) Preparation and biodistribution of 99mTc-IgG–HYNIC in normal rats. Nuklieonika 54:279–284
Barrio MM, Viaggi M, Donaldson M, Portela P, Bover L, Mordoh J, Castiglia SG (2000) Tumor imaging with 99mTc-labeled FC-5.01 monoclonal antibody using a single step labeling method. J Radioanal Nucl Chem 245:337–341
Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PA Jr (1984) Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods 72:77–89
Johnstone A (1996) Immunocytochemistry, immunohistochemistry and flow cytofluorimetry. In: Immunochemistry in practice. Blackwell Science, Berlin
Heydari S, Rajabi H, Rasaneh S, Johari Daha F (2014) Radiolabeling of herceptin with 99mTc as a HER2 tracer. Novel Biomed 2:73–78
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rasaneh, S., Dadras, M.R. The potential of SOCTA as a chelator for radiolabeling of trastuzumab with 99mTc. J Radioanal Nucl Chem 307, 1353–1357 (2016). https://doi.org/10.1007/s10967-015-4314-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-015-4314-z